recent
steadi
increas
number
recogn
pathogen
microorgan
specif
bacteria
develop
genet
technolog
malditof
mass
spectrometri
new
cultur
techniqu
significantli
widen
repertoir
known
microorgan
therefor
pathogen
microorgan
repertoir
infecti
agent
studi
variou
environ
includ
water
soil
pet
livestock
wildlif
arthropod
use
differ
method
mani
known
pathogen
identifi
sampl
therefor
impact
emerg
pathogen
human
examin
novel
pathogen
identifi
special
issu
discuss
identif
emerg
pathogen
environ
anim
recent
steadi
increas
number
recogn
pathogen
microorgan
number
offici
recogn
bacteri
speci
risen
laboratori
evalu
approxim
bacteria
isol
least
human
commens
pathogen
bacteria
addit
recent
show
last
ten
year
hospit
marseil
approxim
differ
pathogen
bacteria
isol
human
specimen
number
virus
isol
human
also
increas
recent
focu
hemorrhag
fever
virus
respiratori
virus
influenza
viru
coronaviru
virus
transmit
arthropod
exampl
toscana
europ
howev
detect
new
speci
protist
fungi
much
slower
appear
reflect
lower
interest
discoveri
emerg
microorgan
final
archaea
group
prokaryot
differ
bacteria
receiv
much
attent
difficulti
associ
cultur
therefor
agent
consid
pathogen
agent
digest
microbiota
essenti
recycl
hydrogen
methan
special
issu
aim
identifi
emerg
differ
pathogen
consid
pathogen
microorgan
exist
environ
anim
inanim
environ
repertoir
microorgan
given
area
base
need
target
diagnost
therapeut
intervent
exist
pathogen
area
recent
studi
limit
technic
expertis
countri
perform
europ
unit
state
strategi
detect
exist
pathogen
base
circul
microorgan
preval
area
therefor
frequenc
pathogen
circul
poor
area
examin
pathogen
consid
emerg
term
reflect
recent
discoveri
rather
recent
creation
repertoir
infecti
agent
evalu
environ
includ
water
soil
pet
livestock
wildlif
arthropod
use
variou
method
mani
known
pathogen
identifi
sampl
therefor
impact
human
assess
microorgan
yet
recogn
pathogen
identifi
systemat
studi
perform
human
identifi
proport
relat
protist
fungi
bacteria
virus
caus
fever
well
acut
chronic
infect
studi
yield
surpris
result
instanc
recent
studi
differ
team
differ
locat
africa
seneg
kenya
reveal
rickettsia
feli
second
microorgan
associ
fever
malaria
furthermor
microorgan
consid
agent
fever
europ
borrelia
recurrenti
caus
tickborn
relaps
fever
infecti
agent
tropheryma
whipplei
coxiella
burnetii
signific
impact
african
popul
notabl
studi
test
differ
popul
must
includ
neg
control
sampl
patient
origin
without
fever
predict
valu
diagnost
test
establish
repertoir
infecti
agent
depend
number
asymptomat
carrier
without
fever
malariaendem
area
nonfebril
carrier
plasmodium
falciparum
recent
unpublish
studi
gabon
nonfebril
children
present
emerg
room
local
hospit
carrier
p
falciparum
blood
addit
r
feli
whipplei
also
observ
nonfebril
patient
examin
reason
therefor
systemat
addit
neg
control
critic
assess
causal
microorgan
genesi
fever
also
essenti
establish
comprehens
multiplex
pathogen
repertoir
suffici
repeatedli
test
common
pathogen
therefor
presenc
p
falciparum
febril
patient
deter
search
pathogen
present
combin
streptococcu
pneumonia
staphylococcu
aureu
establish
microorgan
repertoir
facilit
develop
strategi
diagnosi
infecti
agent
especi
local
african
area
use
point
care
laboratori
enabl
implement
empir
treatment
fig
techniqu
detect
emerg
pathogen
base
sever
strategi
cultur
techniqu
evolv
consider
multipl
strategi
use
produc
differ
axen
cultur
media
easili
use
local
laboratori
without
need
expens
equip
new
media
cultiv
anaerob
microorgan
without
specif
equip
like
facilit
isol
anaerob
bacteria
sensit
oxygen
deriv
develop
human
cell
cultur
hel
cultur
amoeba
enabl
cultiv
new
pathogen
microorgan
laboratori
dakar
oleg
medianikov
success
use
cell
cultur
isol
new
speci
intract
bacteria
rickettsia
bartonella
spp
environment
sampl
new
bacteri
speci
easili
identifi
use
malditof
mass
spectrometri
technolog
use
econom
rapidli
identifi
minut
bacteria
mass
spectra
present
machin
databas
bacteria
identifi
use
malditof
mass
spectrometri
rdna
amplif
sequenc
analysi
use
determin
whether
isol
repres
novel
speci
less
homolog
subsequ
new
mass
spectra
creat
known
speci
later
use
spectra
new
speci
file
malditof
mass
spectrometri
revolution
microbi
identif
enabl
rapid
bacteri
identif
includ
emerg
countri
therefor
collabor
ird
biom
erieux
instal
malditof
mass
spectromet
dakar
enabl
identif
previous
unknown
bacteria
furthermor
malditof
mass
spectrometr
analysi
commens
bacteria
identifi
new
speci
bacteria
observ
either
environ
human
laboratori
systemat
sequenc
bacteri
genom
speci
descript
associ
malditof
mass
spectra
main
morpholog
biochem
characterist
fig
addit
techniqu
specif
molecular
assay
base
univers
amplif
bacteria
play
import
role
commonli
use
techniqu
base
amplif
univers
rdna
gene
facilit
identif
unrecogn
bacteria
especi
anaerob
multimicrobi
infect
amplif
rpob
gene
encod
rna
polymeras
enabl
identif
sever
bacteria
unnot
recent
identif
eukaryot
microorgan
complex
sever
molecular
assay
amplifi
fungi
protist
microscop
arthropod
techniqu
broad
specif
reflect
recent
increas
number
fungi
identifi
human
commens
pathogen
fig
final
metagenom
commonli
defin
sequencedbas
analysi
entir
collect
genom
directli
isol
sampl
use
metagenom
overcom
key
limit
classic
tool
viral
detect
unlik
tradit
techniqu
microbi
viral
identif
metagenom
requir
prior
isol
clonal
cultur
speci
character
reli
prior
assumpt
organ
present
genom
sequenc
target
viral
metagenom
particularli
suitabl
provid
global
overview
divers
viral
commun
function
signific
character
humanassoci
viral
commun
nonpatholog
state
detect
viral
pathogen
infect
essenti
medic
care
epidem
surveil
techniqu
limit
popul
test
howev
techniqu
wide
use
studi
differ
microbiota
might
import
identifi
speci
relat
nutrit
statu
africa
especi
children
suffer
kwashiorkor
due
ongo
global
evolut
mani
new
microorgan
identifi
human
environ
use
combin
differ
technolog
describ
giant
virus
emerg
pathogen
fig
virus
discov
gramposit
bacterium
isol
amoeba
later
identifi
mimiviru
mimiviru
subsequ
isol
human
respiratori
sampl
stool
patient
develop
pneumonia
travel
tunisia
furthermor
serolog
analysi
reveal
increas
preval
virus
patient
pneumonia
canada
virophag
isol
mimiviru
also
identifi
serolog
two
patient
lao
consumpt
raw
fish
mekong
river
also
found
extrem
rich
virophag
final
marseilleviru
discov
amoeb
cultur
later
detect
pcrbase
metagenom
assay
blood
blood
donor
without
clinic
manifest
serolog
hybrid
analysi
lymphnod
child
lymphnod
enlarg
discoveri
giant
virus
possibl
cultur
techniqu
viral
metagenom
analysi
exclud
particl
larger
micron
discoveri
highlight
novel
class
emerg
viral
pathogen
special
issu
identifi
potenti
sourc
emerg
pathogen
microorgan
rapid
develop
genet
molecular
technolog
malditof
mass
spectrometri
new
cultur
techniqu
facilit
identif
microorgan
includ
pathogen
like
develop
diagnost
multiplex
assay
might
gener
problem
diseas
interpret
therefor
multidisciplinari
approach
involv
cultur
malditof
mass
spectrometrybas
identif
metagenom
analysi
environment
human
sampl
gener
comprehens
repertoir
pathogen
microorgan
human
mani
remain
discov
